HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC Credit, Herbalife Q4, Industry Summit: Health And Wellness News

This article was originally published in The Rose Sheet

Executive Summary

GNC approaches closing $300m Hayao investment with lenders' OK to re-work loans; Herbalife back to sales growth and prepares for management changes; and CFSAN's Education Resource Library is accessible as a catalog of nearly 300 publications and videos.

You may also be interested in...



Herbalife Turning A New Leaf While An Old Opponent Folds His Tent

Direct seller Herbalife has a new capital allocation strategy and will ask shareholders for a new name and two-for-one split of its stock. It also has lost an old opponent as hedge fund manager and activist investor William Ackman sheds his investment that would have paid off if Herbalife had gone under.

GNC's New Partner Brings China Access And Funding, Takes Board Seats

As GNC reports substantially trimming its net losses in its 2017 fourth-quarter and full-year results, it announces Harbin Pharmaceutical will invest around $300m in GNC, becoming the single largest shareholder, and the two firms will form a JV for manufacturing, marketing and distributing GNC-branded products in China. With the investment, GNC's board expands from six to 11 members, comprising GNC CEO Ken Martindale, five appointed by Harbin and five by GNC.

Herbalife CEO Plans Exit With FTC-Required Changes Underway

The firm with independent distributors selling nutritional and weight loss products around the world reports third-quarter net income of $87.7m, off 6.3% from the year-ago quarter.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel